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OBJECTIVE: To evaluate the frequency and characteristics of ocular manifestations in outpatients with systemic
sclerosis.
METHODS: In this cross-sectional study, 45 patients with systemic sclerosis were enrolled. Data regarding
demographics, disease duration and subtype, age at diagnosis, nailfold capillaroscopic pattern and autoantibody
profile were collected, and a full ophthalmic examination was conducted. Parametric (Student’s t-test) and
nonparametric (Mann-Whitney U test) tests were used to compare continuous variables. Fisher’s exact test was used
to compare categorical data. P values , 0.05 were considered significant.
RESULTS: Twenty-three subjects (51.1%) had eyelid skin changes; 22 (48.9%) had keratoconjunctivitis sicca, 19
(42.2%) had cataracts, 13 (28.9%) had retinal microvascular abnormalities and 6 (13.3%) had glaucoma. Eyelid skin
changes were more frequent in patients with the diffuse subtype of systemic sclerosis and were associated with a
younger age and an earlier age at diagnosis. Cataracts were presumed to be age-related and secondary to
corticosteroid treatment. There was no association between demographic, clinical or serological data and
keratoconjunctivitis sicca. The retinal microvascular abnormalities were indistinguishable from those related to
systemic hypertension and were associated with an older age and a severe capillaroscopic pattern.
CONCLUSIONS: Eyelid skin abnormalities and keratoconjunctivitis sicca were the most common ocular findings
related to systemic sclerosis. Some demographic and clinical data were associated with some ophthalmic features
and not with others, showing that the ocular manifestations of systemic sclerosis are characterized by heterogeneity
and reflect the differences in the implicated pathophysiological mechanisms.
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findings.
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INTRODUCTION
Systemic sclerosis (SSc) is a generalized connective tissue
disease of unknown origin with heterogeneous manifesta-
tions. It affects different organs and therefore requires
interdisciplinary diagnostic and therapeutic management.1
In the pathophysiology of SSc, three abnormalities have
been distinguished: 1) a fibroblast dysfunction leading to
increased deposition of extracellular matrix; 2) a vascular
abnormality resulting in tissue hypoxia; and 3) an immune
response, manifested as altered T- and B-lymphocyte
function and autoantibody production.2-5
Because SSc is a rare disease, most of the data regarding
ocular involvement consist of single case reports or small
case studies, thereby limiting the generalization of the
findings to a larger population of patients.6,7
Recently, a narrative review conducted by Tailor et al.
reported a wide variability of ophthalmic features in SSc.
Some of these are well-known (i.e., eyelid skin changes and
keratoconjunctivitis sicca), while others are controversial
(primary SSc retinopathy).8
The purpose of this study was to evaluate the frequency and
characteristics of ocular manifestations in outpatients with SSc.
PATIENTS AND METHODS
This cross-sectional study included all consecutive outpatients
with SSc attending the rheumatology service at Clementino
Fraga Filho University Hospital in Rio de Janeiro, Brazil,
between April 2009 and December 2009. All patients fulfilled
the American College of Rheumatology criteria for SSc (Box 1).9
Patients with SSc sine scleroderma, scleroderma overlap
syndrome, diabetes mellitus or severe systemic hyperten-
sion were excluded.
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Data regarding age, gender, SSc subtype (as defined by
LeRoy et al.),10 disease duration, age at diagnosis, nailfold
capillaroscopic pattern,11 autoantibody profile (antinuclear,
anti-topoisomerase I, anti-centromere antibodies), systemic
corticosteroid or chloroquine use, systolic and diastolic
blood pressure, ocular symptoms and detailed ophthalmic
history were recorded. All patients underwent a complete
ophthalmic evaluation by the same physician, who was
unaware of the patients’ clinical and laboratory data.
The capillaroscopic findings were classified as either mild
or severe. Mild findings were characterized by the presence
of giant capillaries, capillary microhemorrhages and a
relatively well-preserved capillary distribution. There was
moderate or no capillary loss, ramified capillaries were
absent or mildly branched and the capillary architecture
was mildly disorganized. Severe findings were character-
ized by the near-absence of giant capillaries and micro-
hemorrhages, and they involved a severe loss of capillaries
and the development of extensive avascular areas, ramified
and bushy capillaries (indicative of neoangiogenesis) and
severe disorganization of the normal capillary array.
The best-corrected visual acuity (BCVA) for distance was
assessed using the Snellen chart, and the BCVA for near
vision was assessed with Jaeger charts. After the vision
assessment, cover test and ocular motility examination,
biomicroscopy was performed.
Dry eye evaluation was performed in the following
sequence: tear break-up time (TBUT), Schirmer I test and
Rose Bengal (RB) staining.
TBUT was measured after 1% fluorescein (Fluore-
sceı´naTM, Allergan, Sa˜o Paulo, SP) instillation. The mean
value of a total of 3 measurements was recorded.
A five-minute conventional Schirmer I test without
anesthesia was performed on closed eyes by placing a
commercially available 5 6 35-mm paper strip (Schirmer
strips TM, Ophthalmos, Sa˜o Paulo, SP) over the lower lid
margin at the junction of the middle and lateral third of the
lower lid margin and into the tear film.
RB staining was performed by touching the inferotem-
poral bulbar conjunctiva with a RB strip (Rose Glo TM, Rose
Stone Enterprises, Alta Loma, CA) dampened with one drop
of a preservative-free isotonic sodium chloride solution.
The reaction was classified according to the van Bijsterveld
scoring system.12
Abnormal test values were as follows: Schirmer test #
5 mm in 5 minutes, TBUT , 10 seconds and RB score . 3.
Patients were diagnosed with definite keratoconjunctivitis
sicca (KCS) if two or more tests were abnormal and with
probable KCS if only one test was abnormal. The diagnosis
of KCS in this study was made by extrapolating the
Japanese13 and Copenhagen criteria.14
Intraocular pressure (IOP) was measured by Goldmann
applanation tonometry. Indirect ophthalmoscopy was per-
formed with an indirect ophthalmoscope and a 20-diopter
lens after both pupils were dilated with 1% tropicamide.
The posterior pole was further evaluated by slit-lamp
biomicroscopy using a 78-D Volk lens.
All patients with suspected glaucoma (IOP . 21 mmHg
in either eye or IOP difference . 5 mmHg between the two
eyes or optic disc suspicious for glaucoma) underwent a
gonioscopy and automated perimetry using a Humphrey
field analyzer. The glaucoma definition that was adopted
has been defined elsewhere.15,16
Statistical analyses were performed using JMP statistical
software (Version 8.0, SAS Institute Inc., USA). Continuous
variables were expressed as the mean ¡ standard deviation,
whereas categorical variables were expressed as frequencies
and their percentages. Parametric (Student’s t-test) and
nonparametric (Mann-Whitney U) tests were used to com-
pare continuous variables, according to the data distribu-
tion. Fisher’s exact test was used to compare categorical
data. P values , 0.05 were considered significant.
RESULTS
Forty-five patients were enrolled in this study. The study
population was between 22 and 77 years old, with an
average age of 51 years. Table 1 shows the demographics of
the study population.
Regarding ophthalmic history, two patients had a history
of recurrent mild episcleritis, and one patient had a history
of central retinal vein occlusion.
Of the 45 patients, 12 (26.7%) had no ocular symptoms.
Among the patients with ocular symptoms, 11 (24.4%)
complained of decreased vision, 6 (13.3%) of itching, 6
(13.3%) of burning, 6 (13.3%) of ocular pain, 5 (11.1%) of
foreign body sensation, 4 (8.9%) of dry eye, 4 (8.9%) of
increased tearing, 3 (6.7%) of floaters, 2 (4.4%) of redness
and 1 (2.2%) of photophobia.
The majority (85.0%) of patients had BCVAs of 20/30 or
better. Four (8.9%) patients had BCVAs of 20/80 or worse in
at least one eye. Low visual acuity was bilateral and caused
by cataracts in three of these patients. One patient had low
visual acuity due to irregular corneal astigmatism devel-
oped after a radial and transverse keratotomy procedure.
Table 1 - Demographic features of the study population.
Characteristics Study population
Average age (yr) 51.0
Range 22-77
SD 12.6
Gender, n (%)
Female 40 (88.9)
Male 5 (11.1)
SSc subtype, n (%)
Limited 27 (60.0)
Diffuse 18 (40.0)
Average duration of SSc (yr) 10.9
SD 9.2
Box 1 - American college of rheumatology
diagnostic criteria for systemic sclerosis. 9
Major criterion
N Proximal sclerodermatous skin changes (proximal
to the metacarpophalangeal joints)
Minor criteria
N Sclerodactyly
N Digital pitting scars of fingertips or loss of sub-
stance of the distal finger pads
N Bibasilar pulmonary fibrosis
* The patient should fulfill the major criterion or two of the
three minor criteria.
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Regarding biomicroscopy and fundoscopy evaluation,
several ocular findings were found and are summarized in
Table 2. In considering the large variety of ocular findings
revealed in this study, some distinctions were made
between those that were probably related to SSc and those
that presumably were not (Table 2).8
Eyelid stiffness was associated with difficulty in lid
eversion and a woody texture upon palpation. Comparing
patients with and without eyelid stiffness (Table 3), we
found that the mean age and the age at diagnosis were
significantly lower in the former group (p = 0.01 and
p = 0.03, respectively). The diffuse subtype was more
prevalent among patients with eyelid skin changes
(p = 0.03).
Cataracts were found in 19 (42.2%) patients. The majority
were classified as a nuclear lens opacity, and the mean age
of patients with cataracts was 59.2 ¡10 years, 14.9 years
older than patients without cataracts (p, 0.001). Addi-
tionally, 89.5% of the patients with cataracts were either
currently taking or had previously taken systemic corticos-
teroids, compared with 60.0% of the patients who did not
have cataracts (p = 0.04).
The prevalence of glaucoma was 13.3%; 5 (11.1%) patients
had open-angle glaucoma, and 1 (2.2%) had angle-closure
glaucoma. The mean IOP was 14.0 ¡ 3.4 mmHg and ranged
from 8 to 24 mmHg. Among patients with glaucoma, 4
(66.7%) were either currently taking or had previously taken
systemic corticosteroids, compared with 75.7% of those
without glaucoma (p = 0.64).
Cornea guttata was found in 2 patients, aged 72 and 77
years old. Spotty areas of iris transillumination, present in
all zones of the iris, were reported in 4 patients and were not
associated with diabetes, intraocular surgery, moderate/
severe myopia or other causative factors for iris changes.
Regarding dry eye evaluation, as many as 38 (84.4%)
patients had TBUT, 10 seconds and 19 (42.2%) patients had
Table 2 - Prevalence of ocular findings.
Ocular finding No. %
Presumed to be
related to SSc
Eyelid stiffness or tightness 23 51.1 yes
Eyelid telangiectasia 23 51.1 yes
Blepharitis 18 40.0 no
Blepharophimosis 1 2.2 yes
Pinguecula 37 82.2 no
Pterygium 7 15.6 no
Shallow fornices 7 15.6 yes
Conjunctival vascular congestion 4 8.9 yes
Loss of fine conjunctival vessels 2 4.4 yes
Keratoconjunctivitis sicca 22 48.9 yes
Cornea guttata 2 4.4 no
Corneal irregular astigmatism 1 2.2 no
Open-angle glaucoma 5 11.1 yes
Angle-closure glaucoma 1 2.2 no
Iris transillumination defects 4 8.9 yes
Cataract 19 42.2 no
Pseudophakia 2 4.4 no
Retinal microvascular abnormalities 13 28.9 yes*
Drusen 2 4.4 no
Central retinal vein occlusion 1 2.2 yes*
Chorioretinal scar 1 2.2 no
Congenital hypertrophy of the RPE 1 2.2 no
Orbital fat atrophy and enophthalmos 3 6.7 yes
Orbital varices with conjunctival varices 1 2.2 no
RPE= retinal pigment epithelium
*Also related to age and systemic hypertension
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Schirmer I test values # 5 mm after 5 minutes in at least one
eye. Total RB staining ranged between 0 and 5. RB scores. 3
were found in 4 (8.9%) patients, while scores$1 were found
in 22 (48.9%) patients. According to the criteria adopted in
this study, 22 patients (48.9%) had a definite and 17 (37.8%)
had a probable diagnosis of KCS. There were no significant
differences in the studied variables between those with a
definite KCS diagnosis and those without, as seen in Table 3.
Retinal microvascular abnormalities were found in 13
(28.9%) patients and included generalized and focal
arteriolar narrowing, arteriovenous nicking, and vascular
tortuosity. A 72-year-old patient had an old central retinal
vein occlusion, characterized by the presence of anastomotic
vessels at the disc and a few residual hemorrhages.
In this study, 26 (57.8%) patients had a diagnosis of
systemic hypertension. The mean systolic blood pressure in
patients with retinal microvascular abnormalities was
124.3¡17.6 mmHg; in patients without retinal microvascu-
lar abnormalities, it was 119.9¡13.5 mmHg (p = 0.22). The
diastolic blood pressure in patients with retinal microvas-
cular changes also did not differ significantly from the
diastolic blood pressure of patients without them (78.5¡
9.0 mmHg versus 75.2 ¡ 8.7 mmHg, p = 0.14). Significantly
more patients with retinal microvascular abnormalities were
diagnosed with systemic hypertension than those without
retinal microvascular abnormalities (100% versus 40.6%, p
,0.001). None of the patients had renal failure. The mean
age of patients with retinal microvascular changes was 11.9
years older than that of patients without these changes
(p = 0.003). In addition, patients with retinal microvascular
findings had a higher prevalence of a nailfold capillaro-
scopic pattern, classified as a severe pattern (87.5% versus
25.0%, p = 0.004), as shown in Table 3. After adjusting for
age and a systemic hypertension diagnosis, the presence of
retinal signs was still significantly associated with a severe
capillaroscopic pattern (p = 0.02).
None of the 11 (24.4%) patients who had been treated
with chloroquine at some point in the disease course had
chloroquine-related maculopathy.
DISCUSSION
Ocular findings in patients with SSc have been reported in
several case reports and in a small number of case series. In
an attempt to obtain more relevant information about the
ocular features of SSc, we evaluated 90 eyes of 45 patients
with SSc. To the authors’ knowledge, the associations of
demographic, clinical and serological data with eyelid
abnormalities and KCS in SSc have not been previously
reported, and the associations with retinal findings have
only been reported in one previous study.
Our findings regarding eyelid skin changes (seen in 51.1%
of the patients) correlate well with previous studies that
showed a prevalence ranging from 29 to 65% of patients.6-8
The most strikingly apparent ocular manifestation of SSc is
the fibrotic change seen in the eyelids.8,17 Skin fibrosis is the
hallmark of SSc and is defined as excess deposition and
accumulation of extracellular matrix, mainly type I collagen,
in the dermis.3 Tailor et al. have shown that skin fibrosis in
SSc patients can result in a spectrum of clinical alterations
ranging from lid stiffness or tightness to blepharophimosis
or lagophthalmos.8
As expected, we found that eyelid skin changes occurred
most commonly in patients who had more extensive skin
involvement; that is, those with the diffuse subtype of SSc.18
Interestingly, we also found that the patients with lid
stiffness were significantly younger and had an earlier
disease onset. It is well known that the diffuse subtype is
associated with a worse prognosis and an earlier disease
onset.10,18,19 However, our study found no significant
association between the subsets of SSc and the presence of
either KCS or retinal microvascular abnormalities.
In previous studies, the extent of skin sclerosis was
revealed to be a useful marker of severity and prognosis.3 At
present, the modified Rodnan skin score (mRSS) is
considered the most appropriate and reproducible techni-
que for measuring skin involvement using palpation in
SSc.18 Because the face is affected in both limited and diffuse
SSc, future studies should address the mRSS in SSc patients
to evaluate whether eyelid stiffness is related to either a
higher total mRSS score or a higher facial skin score.
Over the last decade, studies have identified an associa-
tion between autoantibodies and specific phenotypes of SSc
and, thus, prognosis.20 We found a lack of correlation
between the autoantibody profile and the presence of eyelid
stiffness, KCS, or retinal microvascular changes. We believe
further studies should be conducted to elucidate these
associations. Previous studies have shown correlations
between sicca syndrome and anti-Ro/SSa antibodies in
patients with SSc.21 Anti-Ro/SSA antibodies were not
investigated in this study. The relation between anti-Ro/
SSA antibodies and KCS in SSc patients should be
investigated further.
In this study, symptoms usually related to dry eye, such
as itching, burning, foreign body sensation, dryness, and
redness, were reported by 29 (64.4%) patients and were the
most common complaint. Alarcon-Segovia et al.22 studied
the prevalence of Sjogren’s syndrome in patients with SSc.
They found that of 25 patients with SSc, 18 (72%) described
dry eye symptoms.22
Depending on the study, the prevalence of SSc patients
with KCS varies considerably (37 to 79%),6,7,8,22,23 and the
prevalence found in this study (48.9%) was well within this
range. The observed variation may be partly due to the KCS
definition used and partly due to demographic differences
in the patient populations. A previous study showed that
patients with SSc have a higher prevalence of KCS than
controls (47.8 versus 4.3%, p,0.01).7
To the best of our knowledge, the frequencies of
blepharitis, pterygium and pinguecula in a population of
SSc patients have never been reported before. The pre-
valence of blepharitis found in this study does not appear to
differ markedly from that found in the general population.24
Reports show geographical variation in rates of pterygium
(from 1.2 to approximately 33%).25-27 The prevalence of
pinguecula has been reported to be as high as 70% in some
areas.25 Sun exposure plays an important role in the
development of these two conditions, and reports indicate
higher prevalence rates in tropical areas of the world, such
as Brazil.26,27 Therefore, the high prevalence of these
conditions found in this study is in agreement with expec-
tations for the general population of this area and is
presumably not related to SSc.
West and Barnett studied ocular involvement in 38
patients with scleroderma6 and found that conjunctival
abnormalities, such as injection and vascular sludging,
could be related to SSc, as these abnormalities seem similar
to changes described in the SSc pattern for nailfold
Gomes BAF et al.
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capillaries.6 In our study, we found conjunctival vascular
congestion (8.9%) and a loss of fine conjunctival vessels
(4.4%). In addition to conjunctival vascular abnormalities,
patients with SSc may also present subepithelial fibrosis,
leading to shallowing of the fornices.7,8,17 This was observed
in 15.6% of the patients in our study.
Inflammatory conditions, such as uveitis, episcleritis,
scleritis and peripheral ulcerative keratitis, are well-recog-
nized manifestations of connective tissue disease and have
been reported in SSc patients.7,8,28,29,30,31,32 In this study,
4.4% of the patients had a history of recurrent episcleritis.
We did not find any signs of SSc-related uveitis in our
sample. Instead, we found a chorioretinal scar due to ocular
toxoplasmosis. Indeed, the association between SSc and
uveitis is rare, and only single case reports have been
reported in the peer-reviewed literature.29-31
In a population study, 0.6% of Maryland residents were
found to have scars consistent with ocular toxoplasmosis. In
Brazil, 1.2 to 17.7% of the population has been found to have
retinal lesions suggestive of ocular toxoplasmosis. Thus, it is
very unlikely that chorioretinal scars are related to SSc.33
Although previous reports suggest that some corneal
abnormalities could be related to SSc, such as exposure
keratitis (secondary to lid changes),7 peripheral ulcerative
keratitis,8,32 pellucid marginal degeneration,34 and biome-
chanical abnormalities,35 our findings of cornea guttata
(4.4%) and irregular astigmatism (2.2%) were not consid-
ered to be related to SSc.
Cornea guttata was found in two aged SSc patients. The
frequency of cornea guttata increases with age and has been
reported to be as high as 11% for women older than 50
years. The irregular astigmatism found in one patient was a
complication of a radial and transverse keratotomy proce-
dure.36
The prevalence of open-angle glaucoma was 11.1%, higher
than reported for the general Brazilian population (2.4%).37
Other studies have suggested that collagen disease, including
SSc, may be a risk factor for developing both primary open-
angle glaucoma and normal-tension glaucoma.38,39 Because
we performed only a single IOP measurement, we were
unable to differentiate cases of normal-tension glaucoma
from high-pressure, open-angle glaucoma.
Several manifestations of SSc, including Raynaud’s
phenomenon, digital ulceration, scleroderma renal crisis
and pulmonary arterial hypertension, are caused by
vascular abnormalities.2 Although the pathogenesis of
glaucomatous optic neuropathy is still controversial, there
is increasing evidence that ischemia and vascular deregula-
tion are implicated in the mechanisms underlying glau-
coma.40 Both SSc itself and systemic therapy with
corticosteroids may lead to a higher prevalence of glau-
coma. However, in this study, corticosteroid therapy was
not associated with the diagnosis of glaucoma.
A study by Allanore et al. demonstrated an increased rate
of ocular glaucomatous abnormalities (excavation cup-to-
disc ratio. 0.3 and a visual field mean deviation, -2 dB) in
patients with SSc compared with controls (p ,0.001). The
mean IOP of the SSc patients in their study was 14.7 ¡
3 mmHg, which is similar to the mean IOP found in this
study (14.0 ¡ 3.4 mmHg).39
The majority of the patients in this study had satisfactory
visual acuity. Cataracts were the most common cause of
visual impairment and were found in 42.2% of the study
population. They were presumed to be age-related and may
also be present secondary to systemic corticosteroid treat-
ment.4 In the Framingham Eye Study, senile cataracts were
seen in 15.5% of the general population, and the overall
rates of cataract incidence rapidly increased with age, such
that nuclear cataracts were found in 65.5% of the oldest
group of study participants (75 years and older).41
Iris transillumination defects were found in 8.9% of the
patients in our study. This was previously demonstrated as
an ocular finding in SSc patients, probably as a consequence
of defects in the iris pigment epithelium.6-8
Enophthalmos due to orbital fat atrophy was found in 3
(6.7%) patients and is probably SSc-related. Nontraumatic
enophthalmos is an uncommon condition.42 We hypothe-
size that it could be explained by the dermal fibrosis that
occurs in SSc patients. Orbital fat atrophy is a reported
complication of localized scleroderma and has also been
associated with SSc.8,43,44 Orbital varices have not been
previously reported in SSc and are not directly related to
SSc.
The retinal and choroidal vasculatures appear to provide
an almost ideal window through which to study the
generalized arteriolar and capillary pathology of SSc.17
However, it has often been difficult to separate changes due
to concomitant systemic hypertension from those that are
attributable to SSc itself.8,17,45,46 Involvement of the posterior
segment of the eye is often subclinical.6,7 Reported ophthal-
moscopic findings in patients with SSc include microvas-
cular changes, cotton-wool spots, exudates, cystoid bodies,
retinal and optic nerve head edema, hemorrhages, and
retinal vein and artery occlusion.8,17,47,48,49 These abnorm-
alities appear to be more typical of advanced SSc with renal
involvement and hypertension.8,17 Parafoveal telangiectasia
has also been associated with SSc.50,51
In this study, 28.9% of the patients had retinal micro-
vascular abnormalities that were indistinguishable from
those related to systemic hypertension.52
Retinal microvascular abnormalities seem to be relatively
common in the general population (2 to 14% of the
nondiabetic population aged 40 years and older).53 Several
studies have shown that these abnormalities are associated
with the presence and severity of hypertension.53-55
However, these retinal signs may also be observed in
people without a history of hypertension and may be
related to other diseases.53,54 A population-based study
reported that arteriovenous nicking and arteriolar narrow-
ing were independently associated with a variety of markers
of inflammation and endothelial dysfunction.55 We believe
that the vasculopathy that occurs in SSc may play a role in
the development of retinal vascular abnormalities and may
also contribute to retinal vascular occlusions.
Recently, it has been determined that central retinal vein
occlusion affects 0.8 in 1000 people. In this study, there was
one case of central retinal vein occlusion among the 45
patients studied.56
Ushiyama et al. studied the retinal findings of 29 patients
with SSc and found a higher frequency of retinal changes
associated with vascular damage in SSc patients than in
controls (p = 0.01). However, contrary to this study, they
found no association between nailfold capillary changes and
retinal findings.46 In their study, nailfold capillary changes
were classified into three scleroderma patterns (early, active
and late), as described by Cutolo et al.57 We grouped the
scleroderma patterns into only two groups (mild versus
severe) to allow statistical analysis to be conducted. The
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early and active patterns were grouped together into the
mild capillaroscopic findings group, whereas the late
pattern corresponds to the severe capillaroscopic findings
in this study.11,57
In patients with arterial hypertension, a reduced capillary
density in different body regions has been observed. An
analogous phenomenon of reduction in the nailfold area has
also been observed in a group of patients with essential
hypertension.58 However, the capillaroscopic pattern in SSc
is specific and is characterized by the presence of dilated
and giant capillaries, hemorrhages, avascular areas, and
neoangiogenesis.11,57,59
Several authors have noted that the nailfold capillaro-
scopic pattern in SSc correlates with some clinical symptoms
and with the severity of the disease.60 We found no
association between the capillaroscopic pattern and either
KCS or eyelid abnormalities.
Congenital hypertrophy of the retinal pigment epithelium
has never been described in association with SSc. Its
prevalence in the general population has been reported as
1.2%.61 We believe this was an incidental finding.
Drusen has been reported only in aged patients with SSc.6
In this study, it was found in two elderly patients. The
prevalence of drusen increases with age and has been
reported to be as high as 63% in the general population.62
A limitation of our study is the lack of autoantibody and
capillaroscopy data for all patients. Further studies includ-
ing this information should be conducted.
In conclusion, the ocular manifestations of SSc are
characterized by marked heterogeneity. Eyelid skin
abnormalities and KCS were the most common SSc-related
ocular findings. In the posterior segment of the eye, retinal
microvascular abnormalities indistinguishable from those
related to systemic hypertension were the most common
findings, and they seem to be associated with a severe
capillaroscopic pattern. The prevalence of open-angle
glaucoma was high, suggesting that SSc may be a predis-
posing factor for glaucoma. Patients with SSc may also
develop ocular abnormalities due to systemic therapy.
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